CRYOPDP

What CRYOPDP does

CRYOPDP (legal entity CRYO International S.A.S.) is a France-headquartered temperature-controlled logistics provider specializing in life sciences and healthcare cargo, founded in 1992 and operating as a subsidiary of DHL Group within the DHL Health Logistics brand following its March 2025 acquisition for $195 million. The company delivers pharmaceutical, biopharma, clinical trial, cell and gene therapy, central lab, bulk/heavyweight, and medical device shipments across a network spanning 135+ countries with dedicated facilities in 16 countries across Americas, EMEA, and APAC; it maintains wholly-owned operating subsidiaries in France, Germany, Australia, India, the United States, the United Kingdom, Singapore, the Philippines, Malaysia, South Korea, Russia, and the Netherlands. Temperature coverage ranges from ambient (controlled room temperature) through refrigerated (2-8°C), frozen, deep-frozen, and cryogenic (-150°C to -196°C) for Advanced Therapy Medicinal Products including cell and gene therapies with patient-specific chain of custody.

The company's core offering combines specialized logistics services (Clinical Trials, Cell and Gene, Pharma, Central Labs, Bulk and Heavyweight, Medical Device) with modular value-added services such as Direct-to-Patient, Onboard Courier, White Gloves, Lab Move, customs clearance, lane assessment, and pick-and-pack, supported by an in-house technology stack of IoT real-time monitoring, AI-powered logistics analytics for routing and timing optimization, and the Atlas Path blockchain platform co-developed with Applied Blockchain (recipient of the 2025 SAP Digital Transformation Award). Compliance anchors the positioning: GDP-aligned processes, applicable GMP practices, and IATA-backed transport across multiple jurisdictions.

Revenue is generated on a quote-based pricing model per shipment profile, with services sold directly through enterprise field sales and supported by industry-event presence (e.g., CTS Europe). Customer segments are heavily weighted toward enterprise pharmaceutical and biopharma buyers, central labs, CROs, and ATMP developers, with named customers including hVIVO and undisclosed central lab and pharmaceutical clients; the company is privately held and does not publicly disclose revenue. The company employs 251-500 people, reports to a CFO (Ajay Ranade), and operates under a regional office model (headquarters in Tremblay-en-France, France, with regional HQs in Morris Plains, NJ; Mumbai, India; and Sydney, Australia).

Name

CRYOPDP

Legal name

CRYO International S.A.S.

Website

https://cryopdp.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

251–500 employees

Short description

CRYOPDP is a France-headquartered, DHL Group-owned temperature-controlled logistics provider for life sciences, serving pharmaceutical, biopharma, clinical trial, cell and gene therapy, central lab, and medical device clients across 135+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Cold Chain Logistics

NAICS

Refrigerated Warehousing and Storage (493120), Refrigerated Warehousing and Storage (49312)

SIC

Air Courier Services (4513), Public Warehousing & Storage (4220)

akta.pro primary industry

Cryogenic Logistics (LN2 Dry Shippers, -150°C) (HLAGAMAB)

akta.pro secondary industries

Cryogenic & Ultra-Low Temperature Logistics (-80°C, LN2 Dry Shipper) (TLAIAIAK), Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Cryogenic / Ultra-Low Temperature Transport (e.g., dry ice, LN2) (TLADAHAJ), Life Sciences Cold Chain Logistics (2–8°C, -20°C, -80°C) (HLAGAMAA)

Keywords

• Temperature-controlled logistics
• Pharmaceutical cold chain
• Clinical trial logistics
• Cell gene therapy logistics
• Biopharma distribution

Headquarters

HQ city

Tremblay

HQ country

France

HQ region

Europe

Offices17 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Clinical Trials Logistics Services: CRYOPDP provides temperature-controlled logistics for clinical trial materials, biological samples, and investigational medicinal products (IMPs) with global reach across Americas, EMEA, and APAC regions.
2. Cell and Gene Therapy Logistics: Specialized logistics services for Advanced Therapy Medicinal Products (ATMPs) including cell and gene therapies requiring cryogenic temperatures as low as -196°C to -150°C, supporting patient-specific treatments.
3. Pharmaceutical Distribution: Temperature-controlled transport services for commercial pharmaceutical products including ambient, refrigerated, frozen, and deep-frozen shipments with GDP-compliant handling.
4. Central Lab Logistics: Logistics solutions for central laboratories including transport of biological samples, lab kits, reagents, and research materials with validated packaging and real-time tracking.
5. Bulk and Heavyweight Pharmaceutical Transport: Specialized handling and transport of oversized pharmaceutical equipment and raw materials requiring temperature control and regulatory compliance across regions.
6. Medical Device Shipping: Specialized logistics for medical devices including cutting-edge singular devices and hospital equipment transport with regulatory compliance.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

CRYOPDP provides tailor-made temperature-controlled logistics solutions for life sciences and healthcare cargo, covering ambient, refrigerated, frozen, deep-frozen, and cryogenic temperatures down to -196°C. Core services include clinical trials logistics, cell and gene therapy logistics, pharmaceutical distribution, central lab logistics, and bulk/heavyweight pharmaceutical transport, all delivered with GDP- and GMP-compliant processes.

Product overview

CRYOPDP is a temperature-controlled logistics provider for life sciences and healthcare, operating as part of DHL Health Logistics. The company offers a modular platform combining core logistics services (Clinical Trials Logistics, Cell and Gene Logistics, Pharma Solution, Central Labs Solution, Bulk and Heavyweight Solution) with specialized temperature-controlled packaging solutions (passive, active, dry vapor shippers, vehicles) and value-added services (Direct-to-Patient, Lab Move Solutions, White Gloves, Onboard Courier). Supporting infrastructure includes the Global Control Tower for centralized monitoring, IT Systems for Logistics leveraging IoT/AI/blockchain technologies, and consultancy services (Study Setup Centre, Green Light Process, Lane Assessment, Customs Clearance). The company supplies cryogenic materials (Dry Ice, Liquid Nitrogen) and has developed Atlas Path, a blockchain-based compliance platform with Applied Blockchain. CRYOPDP operates across 16 countries with network coverage in 135+ countries, serving pharma, biopharma, and advanced therapy clients.

Differentiator

Problem solved

Functional benefit

Brands

• Atlas Path: Blockchain-based platform developed in partnership with Applied Blockchain for healthcare logistics that improves shipment visibility and compliance.

Products and services

• Clinical Trials Logistics Comprehensive temperature-controlled logistics service for clinical trials covering central labs, pharma, bulk/heavyweight, and cell and gene solutions with validated packaging, real-time tracking, and 24/7 support. Designed for pharmaceutical and biopharma sponsors conducting global clinical trials, including investigational medicinal product (IMP) transport and biological sample movement across Americas, EMEA, and APAC.
• Cell and Gene Logistics Specialized logistics solution for Advanced Therapy Medicinal Products (ATMPs) including cell and gene therapy programs, supporting patient-specific therapies with strict temperature control down to -196°C cryogenic conditions, chain-of-custody management, traceability, and direct-to-patient delivery models. Built for cell and gene therapy developers, biotech sponsors, and ATMP manufacturers.
• Pharma Solution Temperature-controlled logistics service for the pharmaceutical industry supporting ambient, refrigerated, frozen, and deep-frozen shipments, clinical trial logistics for IMPs, direct-to-patient solutions, and lab kit distribution under GDP-compliant processes. Targeted at pharmaceutical manufacturers and distributors moving commercial temperature-sensitive drug products.
• Central Labs Solution Transport service for central lab logistics handling biological samples, lab kits, reagents, and clinical trial materials with validated packaging and real-time tracking to ensure sample integrity. Designed for central laboratories and clinical research organizations running multi-site global trials.
• Bulk and Heavyweight Solution Temperature-controlled transport service for oversized pharmaceutical freight and heavyweight shipments across Americas, EMEA, and APAC with GDP- and GMP-compliant processes and cross-border documentation management. Targeted at manufacturers and shippers of large pharmaceutical equipment and raw materials.
• Temperature-Controlled Packaging Standalone packaging solutions including passive systems, dry vapor shippers, active solutions, and temperature-controlled vehicles covering all temperature ranges from ambient to cryogenic, providing validated insulation and refrigeration for life sciences and healthcare cargo.
• Global Control Tower Centralized monitoring and reporting service specifically for cell and gene therapy shipments, providing 24/7 coordination of shipment status updates and proactive escalation when shipment conditions change. Offered to ATMP developers requiring continuous visibility and rapid intervention.
• Medical Device Shipping Specialized logistics service for medical devices including cutting-edge singular devices and hospital equipment transport with regulatory compliance and careful handling. Built for medical device manufacturers and healthcare providers distributing temperature-sensitive devices.
• IT Systems for Logistics Technology infrastructure platform combining IoT real-time condition monitoring, AI-powered logistics analytics, and blockchain-based tracking systems to deliver end-to-end shipment visibility, anomaly detection, and proactive risk management for cold chain logistics operations.

Quantifiable outcome

• Direct-to-patient delivery models enable decentralized clinical trials and improve patient access to therapies

Named customers3 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

One partnership is on record.

• DHL Group (DHL Health Logistics)coreStrategic or Co-development Partner · 1 March 2025CRYOPDP was acquired by DHL Group in March 2025 for $195 million to strengthen DHL's temperature-controlled logistics capabilities for clinical trials, biopharma, and cell and gene therapies. The acquisition is part of DHL's Strategy 2030 and €2 billion healthcare logistics investment plan. CRYOPDP now operates under DHL Health Logistics brand, enabling end-to-end healthcare logistics solutions globally.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• World Courier: World Courier (a Cencora/AmerisourceBergen company) is a direct competitor specializing in temperature-controlled pharma logistics and clinical trial supply chain services, with comparable cryogenic and global specialty courier capabilities.
• Marken: Marken (owned by UPS Healthcare) is a leading global provider of clinical trial logistics and biopharma supply chain solutions, directly competing with CRYOPDP in temperature-controlled pharma and cell/gene therapy logistics.
• Biocair: Biocair is a specialist courier for life sciences with deep expertise in cryogenic and temperature-controlled transport, serving pharma and clinical trial clients globally - a near-direct competitor to CRYOPDP's core offering.

Broad incumbents

• DHL Supply Chain Healthcare: DHL Supply Chain's healthcare and life sciences division is now CRYOPDP's parent under DHL Health Logistics, providing broader cold chain warehousing and distribution services that overlap with CRYOPDP's specialized offering.
• FedEx Custom Critical: FedEx Custom Critical provides expedited, time-sensitive and temperature-controlled transportation for healthcare and life sciences shipments, competing with CRYOPDP in specialized pharma logistics.

Others

• Sonoco ThermoSafe: Sonoco ThermoSafe is a major manufacturer of temperature-controlled packaging solutions (including passive and active containers) used by CRYOPDP and its peers; a key supplier and ecosystem partner in the cold chain.
• Pelican BioThermal: Pelican BioThermal provides reusable temperature-controlled shipping containers for life sciences, including deep-frozen and cryogenic solutions, competing with CRYOPDP's packaging offerings.
• va-Q-tec: va-Q-tec manufactures high-performance thermal containers and phase-change materials used for temperature-controlled pharma logistics, an enabling supplier to CRYOPDP and its competitors.
• CSafe Global: CSafe Global manufactures active and passive temperature-controlled shipping containers for the pharma cold chain, serving as a packaging supplier and ecosystem participant in CRYOPDP's delivery model.

Emerging players

• LifeConEx: LifeConEx is a Lufthansa Cargo joint venture focused on temperature-controlled life sciences logistics, an emerging specialized player with partial overlap to CRYOPDP's pharma and clinical trial offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/people/CRYOPDP/61500000000000
• LinkedInlinkedin.com/company/cryopdp

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CRYOPDP